Zenotech Laboratories Ltd

₹ 63.3 0.32%

21 May - close price

zenotechlab.com BSE: 532039

About

Incorporated in 1989, Zenotech Laboratories Ltd is in the business of manufacturing biotechnology products^[1]

Key Points

Business Overview:^[1]
ZTLL is a part of Sun Pharmaceuticals Industries Ltd. It does manufacturing and marketing of pharmaceuticals and bio-pharmaceutical products. It is a pharmaceutical specialty
generic injectables company engaged in the area of manufacturing Oncology, bio-technology and General Injectables products

Website BSE

Market Cap ₹ 387 Cr.
Current Price ₹ 63.3
High / Low ₹ 108 / 51.0
Stock P/E 84.0
Book Value ₹ 15.8
Dividend Yield 0.00 %
ROCE 9.40 %
ROE 4.93 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.

Cons

Stock is trading at 4.02 times its book value
Though the company is reporting repeated profits, it is not paying out dividend
The company has delivered a poor sales growth of 10.6% over past five years.
Company has a low return on equity of 9.56% over last 3 years.
Debtor days have increased from 40.3 to 63.2 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
	8.42	12.37	10.29	8.80	10.98	9.26	11.53	10.94	9.11	9.91	9.77	11.24	12.13
	5.19	5.28	5.29	5.22	5.95	5.59	6.01	5.67	6.33	6.48	7.36	7.37	7.66
Operating Profit	3.23	7.09	5.00	3.58	5.03	3.67	5.52	5.27	2.78	3.43	2.41	3.87	4.47
OPM %	38.36%	57.32%	48.59%	40.68%	45.81%	39.63%	47.88%	48.17%	30.52%	34.61%	24.67%	34.43%	36.85%
	0.49	0.05	0.65	0.16	0.23	0.20	0.19	0.28	0.33	0.34	1.69	1.00	0.44
Interest	0.15	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	1.73	1.79	1.81	1.80	1.78	1.80	1.81	1.74	1.73	1.73	1.75	1.76	1.73
Profit before tax	1.84	5.24	3.84	1.94	3.48	2.07	3.90	3.81	1.38	2.04	2.35	3.11	3.18
Tax %	-666.85%	28.05%	28.12%	28.35%	-5.17%	29.95%	27.18%	11.55%	51.45%	37.25%	42.55%	45.66%	61.32%
	14.12	3.77	2.77	1.38	3.67	1.44	2.83	3.36	0.66	1.29	1.35	1.69	1.23
EPS in Rs	2.31	0.62	0.45	0.23	0.60	0.24	0.46	0.55	0.11	0.21	0.22	0.28	0.20
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	2.75	4.08	2.06	2.25	11.14	13.03	26.02	22.45	36.57	42.42	40.83	43.05
	19.75	24.14	9.73	12.65	19.01	16.54	17.04	16.07	19.11	21.71	23.56	28.87
Operating Profit	-17.00	-20.06	-7.67	-10.40	-7.87	-3.51	8.98	6.38	17.46	20.71	17.27	14.18
OPM %	-618.18%	-491.67%	-372.33%	-462.22%	-70.65%	-26.94%	34.51%	28.42%	47.74%	48.82%	42.30%	32.94%
	2.39	0.35	0.04	1.91	2.37	4.71	7.54	0.41	0.63	1.08	0.96	3.47
Interest	4.69	6.65	7.55	7.50	2.45	0.12	0.89	1.55	1.22	0.11	0.00	0.00
Depreciation	3.56	4.06	3.96	3.87	3.90	4.20	4.85	6.46	6.97	7.17	7.09	6.96
Profit before tax	-22.86	-30.42	-19.14	-19.86	-11.85	-3.12	10.78	-1.22	9.90	14.51	11.14	10.69
Tax %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-123.94%	20.12%	25.49%	47.52%
	-22.86	-30.41	-19.14	-19.87	-11.85	-3.13	10.78	-1.22	22.18	11.59	8.30	5.61
EPS in Rs	-3.75	-4.99	-3.14	-3.26	-1.94	-0.51	1.77	-0.20	3.63	1.90	1.36	0.92
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	27%
5 Years:	11%
3 Years:	6%
TTM:	5%

Compounded Profit Growth
10 Years:	8%
5 Years:	1%
3 Years:	-41%
TTM:	-45%

Stock Price CAGR
10 Years:	5%
5 Years:	24%
3 Years:	5%
1 Year:	2%

Return on Equity
10 Years:	%
5 Years:	12%
3 Years:	10%
Last Year:	5%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	34.43	34.43	34.43	34.43	61.03	61.03	61.03	61.03	61.03	61.03	61.03	61.03
Reserves	-31.17	-61.68	-80.49	-100.33	-19.01	-22.13	-11.40	-12.62	9.61	21.24	29.51	35.10
	46.92	54.32	54.29	54.28	0.00	20.24	21.42	20.66	6.00	0.00	0.00	0.00
	20.01	36.64	44.69	62.37	39.72	25.45	14.51	16.78	17.45	18.61	15.66	14.90
Total Liabilities	70.19	63.71	52.92	50.75	81.74	84.59	85.56	85.85	94.09	100.88	106.20	111.03
	56.25	52.13	48.17	46.83	44.43	43.11	48.73	74.23	70.91	65.38	65.58	60.87
CWIP	0.00	0.00	0.00	0.00	2.32	16.95	29.08	2.18	0.28	4.98	1.96	3.57
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	13.94	11.58	4.75	3.92	34.99	24.53	7.75	9.44	22.90	30.52	38.66	46.59
Total Assets	70.19	63.71	52.92	50.75	81.74	84.59	85.56	85.85	94.09	100.88	106.20	111.03

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	-24.30	-7.72	-4.80	1.64	-16.25	-14.04	11.38	5.74	17.67	20.66	11.82	9.49
	-0.50	0.34	5.50	-0.69	-2.65	-16.19	-20.79	-4.82	-1.84	-5.82	-21.15	15.29
	29.63	6.77	-0.83	-0.72	46.83	15.02	-2.70	0.45	-15.87	-6.11	0.00	0.00
Net Cash Flow	4.83	-0.60	-0.13	0.23	27.92	-15.21	-12.11	1.38	-0.04	8.73	-9.33	24.78

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	11.95	35.78	62.01	0.00	0.00	66.11	26.09	61.78	39.22	28.57	29.05	63.16
Inventory Days	562.10	232.69	305.45	202.29	374.12	294.03
Days Payable	487.64	222.42	816.45	1,127.98	2,468.31	2,088.61
Cash Conversion Cycle	86.41	46.05	-448.99	-925.69	-2,094.19	-1,728.47	26.09	61.78	39.22	28.57	29.05	63.16
Working Capital Days	-2,416.96	-3,294.84	-8,061.89	-10,395.20	-1,218.52	-537.00	-171.00	-163.56	-106.00	-98.86	-62.93	-27.98
ROCE %	-39.28%	-61.54%	-65.67%		-61.84%	-5.93%	8.14%	0.47%	15.26%	18.35%	12.94%	9.40%

Shareholding Pattern

Numbers in percentages

	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
	68.84%	68.84%	68.84%	68.84%	68.84%	68.84%	68.84%	68.84%	68.84%	68.84%	68.84%	68.84%
	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%
	0.00%	0.98%	0.98%	0.98%	0.98%	0.98%	0.98%	0.98%	0.98%	0.98%	0.98%	0.98%
	31.15%	30.18%	30.17%	30.17%	30.18%	30.17%	30.17%	30.17%	30.16%	30.18%	30.18%	30.18%
No. of Shareholders	8,014	7,930	8,746	9,142	9,249	9,589	9,762	9,819	9,750	10,641	10,667	10,690

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	66.85%	68.84%	68.84%	68.84%	68.84%	68.84%	68.84%	68.84%	68.84%
	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.98%	0.98%	0.98%
	33.14%	31.15%	31.15%	31.15%	31.15%	31.15%	30.17%	30.17%	30.18%
No. of Shareholders	5,838	6,252	6,381	6,187	6,537	7,760	9,142	9,819	10,690

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Zenotech Laboratories Ltd

Zenotech Laboratories Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports